Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company. It manufactures active pharmaceutical ingredients in cough and cold segment, as well as in other therapeutic segments.
Malladi Drugs And Pharmaceuticals Limited, is an unlisted public company incorporated on 21 August, 1980. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 70.00 cr and the total paid-up capital is INR 63.93 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Dilip Keshavlal Patel | 00013150 | 10 years |
Nominee Director | Vishar Vasudevan Subramanian | 00130205 | 3 years |
Whole-time Director | Prashant Malladi
Shareholder
|
00133341 | 14 years |
Managing Director | Shreya Sistla
Shareholder
|
00133354 | 26 years |
Whole-time Director | Venganelloor Narayanaswami Gopalakrishnan | 00198785 | 14 years |
Director | Revathi Raghunathan | 01254043 | 1 years |
Director | Parvathi Malladi
Shareholder
|
01498852 | 7 years |
Nominee Director | Tirunelveli Padmanabhan Devarajan | 03473633 | 3 years |
Kmp | Sandip Neogi | <HIDDEN> | 2 years |
Director | Hariharan Sivaramakrishnan | 10272165 | 2 years |
CS | Kanagasabesan Karthik | <HIDDEN> | 3 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Union Bank of India
No. of Loans: 1
Total Amount : 297.3 cr
RBL Bank Limited
No. of Loans: 2
Total Amount : 115.0 cr
Axis Bank Limited
No. of Loans: 2
Total Amount : 83.5 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 67.7 cr
Bank of Baroda
No. of Loans: 1
Total Amount : 20.0 cr
FIRST LEASING CO OF INDIA LIMITED
No. of Loans: 1
Total Amount : 0.2 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
TANTECH AGRO CHEMICALS LIMITED | Tamil Nadu | 1989 | ₹ 3.8 Cr |
NOVUS FINE CHEMICALS, LLC | United States | - | - |
NOVUS FINE CHEMICALS, LLC | United States | - | - |
Read more
The incorporation date of MALLADI DRUGS AND PHARMACEUTICALS LIMITED is 21 August, 1980
The authorized share capital of MALLADI DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 70.0 Cr.
The paid-up capital of MALLADI DRUGS AND PHARMACEUTICALS LIMITED is INR ₹ 63.9 Cr.
The registered address of MALLADI DRUGS AND PHARMACEUTICALS LIMITED is SKCL Tech Square, 7th Floor, Plot no. SP 14, Thiru Vi Ka Industrial Estate, Guindy Chennai Chennai Tamil Nadu - 600032
The CIN number of MALLADI DRUGS AND PHARMACEUTICALS LIMITED is U24230TN1980PLC008382.